RUTH MOZE: Open Payments
NPI 1205206893 · BALDWIN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,548 in 33 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,548
Food & beverage: $1,548
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $411 |
| Axsome Therapeutics, Inc. | 3 | $347 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $183 |
| ABBVIE INC. | 2 | $142 |
| Braeburn Inc. | 2 | $140 |
| Neurocrine BioSciences, Inc. | 3 | $89 |
| Janssen Pharmaceuticals, Inc | 2 | $79 |
| Lundbeck LLC | 2 | $41 |
| Corium, LLC | 2 | $26 |
| Almatica Pharma LLC | 1 | $22 |
Products named: Auvelity, LYBALVI, CAPLYTA, ARISTADA, VRAYLAR, BRIXADI, INGREZZA, SPRAVATO.
Industry payments across NY — which companies pay providers there.
